Influence of metformin on GLUT1 gene and protein expression in rat streptozotocin diabetes mellitus model

Archives of Physiology and Biochemistry

Volumn 116, Issue 3, 2010, Pages 137-145

  Sokolovska, Jelizaveta ^a   Isajevs, Sergejs ^b   Sugoka, Olga ^b   Sharipova, Jelena ^a   Lauberte, Lasma ^a   Svirina, Darja ^b   Rostoka, Evita ^a   Sjakste, Tatjana ^b   Kalvinsh, Ivars ^a   Sjakste, Nikolajs ^a,b  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^b UNIVERSITY OF LATVIA   (Latvia)

Author keywords

Anti diabetic; Experimental; Glucose transport; Glycaemia; Glycated haemoglobin

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; GLUCOSE TRANSPORTER 1; GLYCOSYLATED HEMOGLOBIN; METFORMIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; DISEASE MODEL; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE TOLERANCE TEST; MALE; METABOLISM; PATHOLOGY; RAT; WISTAR RAT; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; RATS; RATS, WISTAR;

RATTUS;

EID: 77954767650     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2010.494672     Document Type: Article

References (36)

1. Bailey CJ, Day C. (2004). Metformin: its botanical background. Practical Diabetes International 21:115-117
2. Bailey CJ, Turner RC. (1996). Metformin. N Engl J Med 334:574-579
3. Barnes K, Ingram JC, Porras OH, Barros LF, Hudson ER, Fryer LG, Foufelle F, Carling D, Hardie DG, Baldwin SA. (2002). Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK). J Cell Sci 115:2433-2442
4. Bouché C, Serdy S, Kahn CR, Goldfine AB. (2004). The cellular fate of glucose and its relevance in type 2 diabetes. Endocrine Rev 25:807-830
5. Brosius FC, Heilig CW. (2005). Glucose transporters in diabetic nephropathy. Pediatr Nephrol 20:447-451
6. Collier CA, Bruce CR, Smith AC, Lopaschuk G, Dyck DJ. (2006). Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle. Am J Physiol Endocrinol Metab 29:E182-89.
7. Cortes P, Riser BL, Asano K, Rodríguez-Barbero A, Narins RG, Yee J. (1998). Effects of oral antihyperglycaemic agents on extracellular matrix synthesis by mesangial cells. Kidney Int 54:1985-1998.
8. Depre C, Young ME, Ying J, Ahuja HS, Han Q, Garza N, Davies PJ, Taegtmeyer H. (2000). Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J Mol Cell Cardiol 32:985-996
9. Di Stefano A, Caramori G, Oates T, Capelli A, Lusuardi M, Gnemmi I, Ioli F, Chung KF, Donner CF, Barnes PJ, Adcock IM. (2000). Increased expression of nuclear factor-?B in bronchial biopsies from smokers and patients with COPD. Eur Respir J 20:556-563
10. Fischer Y, Thomas J, Rösen P, Kammermeier H. (1995). Action of metformin on glucose transport and glucose transporter GLUT1 and GLUT4 in heart muscle cells from healthy and diabetic rats. Endocrinology 136:412-420
11. Forcheron F, Abdallah P, Basset A, del Carmine P, Haffar G, Beylot M. (2009). Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate. Obesity 17:1381-1389
12. Fryer LG, Foufelle F, Barnes K, Baldwin SA, Woods A, Carling D. (2002). Characterization of the role of the AMP-activated protein kinase in the stimulation of glucose transport in skeletal muscle cells. Biochem J 363:167-174
13. Haukeland JW, Konopski Z, Eggesbø HB, von Volkmann HL, Raschpichler G, Bjøro K, Haaland T, Løberg EM, Birkeland K. (2009). Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial. Scand J Gastroenterol 44:853-860
14. Heishi M, Hayashi K, Ichihara J, Ishikawa H, Kawamura T, Kanaoka M, Taiji M, Kimura T. (2008). Comparison of gene expression changes induced by biguanides in db/db mice liver. J Toxicol Sci 33:339-347
15. Hirode M, Ono A, Miyagishima T, Nagao T, Ohno Y, Urushidani T. (2008). Gene expression profiling in rat liver treated with compounds inducing phospholipidosis. Toxicol Appl Pharmacol 229:290-299
16. Hundal R, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, Inzucchi S, Schumann W, Petersen K, Landau B, Shulman G. (2000). Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49:2063-2069
17. Hundal HS, Ramlal T, Reyes R, Leiter LA, Klip A. (1992). Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. Endocrinology 131:1165-1173
18. Hwang D-Y, Ismail-Beigi F. (2001). Stimulation of GLUT-1 glucose transporter expression in response to hyperosmolarity. Am J Physiol Cell Physiol 281:C1365-72.
19. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN. (1995). Histological grading and staging of chronic hepatitis. J Hepatol 22:696-699
20. Kainulainen H, Breiner M, Schürmann A, Marttinen A, Virjo A, Joost HG. (1994). In vivo glucose uptake and glucose transporter proteins GLUT1 and GLUT4 in heart and various types of skeletal muscle from streptozotocin-diabetic rats. Biochim Biophys Acta 1225:275-282
21. Kirpichnikov D, McFarlane SI, Sowers JR. (2002). Metformin: an update. Ann Intern Med 137:25-33.
22. Krakoff J, Clark JM, Crandall JP, Wilson C, Molitch ME, Brancati FL, Edelstein SL, Knowler WC. (2010). Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program. Obesity E-pub ahead of print.
23. Lee MJ, Feliers D, Mariappan MM, Sataranatarajan K, Mahimainathan L, Musi N, Foretz M, Viollet B, Weinberg JM, Choudhury GG, Kasinath BS. (2007). A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol 292:F617-27.
24. Loomba R, Lutchman G, Kleiner DE, Ricks M, Feld JJ, Borg BB, Modi A, Nagabhyru P, Sumner AE, Liang TJ, Hoofnagle JH. (2009). Clinical trial: pilot study of metformin for the treatment of nonalcoholic steatohepatitis. Aliment Pharmacol Ther 29:603-604
25. Nobili V, Manco M, Ciampalini P, Alisi A, Devito R, Bugianesi E, Marcellini M, Marchesini G. (2008). Metformin use in children with nonalcoholoc fatty liver disease: an open-label, 24-month, observational study. Clin Ther 30:1168-1176
26. Ojuka EO. (2004). Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle. Proc Nutr Soc 63:275-278
27. Rouru J, Koulu M, Peltonen J, Hänninen V, Pesonen U, Huupponen R. (1995). Effects of metformin treatment on glucose transporter proteins in subcellular fractions of skeletal muscle in (fa/fa) Zucker rats. Br J Pharmacol 115:1182-1187
28. Saeedi R, Parsons HL, Wambolt RB, Paulson K, Sharma V, Dyck JR, Brownsey RW, Allard MF. (2008). Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms. Am J Physiol Heart Circ Physiol 294:H2497-506.
29. Towler MC, Hardie DG. (2007). AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 100:328-341
30. Uygun A, Kadayifci A, Isik AT, Ozgurtas T, Deveci S, Tuzun A, Yesilova Z, Gulsen M, Dagalp K. (2004). Metformin in the treatment of patients with non-alcoholoc steatohepatitis. Aliment Pharmacol Ther 19:537-544
31. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034.
32. Yan J, Young M, Cui L, Lopaschuk GD, Liao R, Tian R. (2009). Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity. Circulation 119:2818-2828
33. Yang J, Holman GD. (2006). Long-term metformin treatment stimulates cardiomyocyte glucose transport through an AMPactivated protein kinase-dependent reduaction in GLUT4 endocytosis. Endocrinology 147:2728-2736
34. Ybarra J, Behrooz A, Gabriel A, Koseoglu MH, Ismail-Beigi F. (1997). Glycemia-lowering effect of cobalt chloride in the diabetic rat: increased GLUT1 mRNA expression. Mol Cell Endocrinol 133:151-160
35. Zhang L, He H, Balschi JA. (2007). Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration. Am J Physiol Heart Circ Physiol 293:H457-66.
36. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman M, Goodyear L, Moller D. (2001). Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174.